|Project Title||Principal Investigator||Institution|
|Treatment of sleep problems in children with autism spectrum disorder with melatonin: A double-blind, placebo-controlled study||Glaze, Daniel||Baylor College of Medicine|
|Autism Intervention Research Network on Physical Health (AIR-P network)||Perrin, James||Massachusetts General Hospital|
|Cognitive-behavioral group treatment for anxiety symptoms in adolescents with high-functioning autism spectrum disorders||Reaven, Judy||University of Colorado Denver|
|Autistic enterocolitis/Crohn's||Balzola, Frederico||University of Turin|
|Melatonin for sleep in children with autism: Safety, tolerability, and dosing||Malow, Beth||Vanderbilt University|
|Melatonin for sleep in children with autism: Safety, tolerability, and dosing (supplement)||Malow, Beth||Vanderbilt University Medical Center|
|IACC Strategic Plan Objective||2008||2009||2010||2011||2012||Total|
|Support at least three randomized controlled trials that address co-occurring medical conditions associated with ASD by 2010.
IACC Recommended Budget: $13,400,000 over 3 years
|4.S.A. Funding: The recommended budget for this objective was met.
Progress: More than three projects were funded, including trials of sleep, anxiety, seizure and gastrointestinal (GI) interventions, meeting the objective. Additional work will be needed in the future to fully address these conditions.
Remaining Gaps, Needs, and Opportunities: Sleep issues, anxiety, hyperactivity and GI issues are key co-occurring medical conditions in patients with ASD. Although there is much more known today about sleep initiation than what was understood 5 years ago, there is little understanding of what interventions/treatments are effective for sleep maintenance or night awakening. There is not much known concerning anxiety treatments for those with ASD, and challenges exist regarding the adaptation of anxiety treatments from outside ASD patient groups. Research into interventions for hyperactivity may be transferred from populations outside of those with ASD (i.e., ADHD). Though there has been an increased awareness of gastrointestinal difficulties and common symptoms among people with ASD, little is known about the etiology of autism-related GI issues. More research on the etiology of GI issues will be needed to develop appropriate treatments/interventions.